Author:
Mosconi Lisa,Williams Schantel,Carlton Caroline,Zarate Camila,Boneu Camila,Fauci Francesca,Ajila Trisha,Nerattini Matilde,Jett Steven,Andy Caroline,Battista Michael,Pahlajani Silky,Osborne Joseph,Brinton Roberta Diaz,Dyke Jonathan P.
Abstract
AbstractEmerging evidence implicates chronic psychological stress as a risk factor for Alzheimer’s disease (AD). Herein, we examined the relationships between serum cortisol and multimodality brain AD biomarkers in 277 cognitively normal midlife individuals at risk for AD. Overall, higher cortisol was associated with lower total brain volume, lower glucose metabolism (CMRglc) in frontal cortex, and higher β-amyloid (Aβ) load in AD-vulnerable regions; and marginally associated with phosphocreatine to ATP ratios (PCr/ATP) in precuneus and parietal regions. Sex-specific modification effects were noted: in women, cortisol exhibited stronger associations with Aβ load and frontal CMRglc, the latter being more pronounced postmenopause. In men, cortisol exhibited stronger associations with gray matter volume and PCr/ATP measures. Higher cortisol was associated with poorer delayed memory in men but not in women. Results were adjusted for age, Apolipoprotein E (APOE) epsilon 4 status, midlife health factors, and hormone therapy use. These results suggest sex-specific neurophysiological responses to stress, and support a role for stress reduction in AD prevention.
Funder
National Institute on Aging
NIH/NCATS
Publisher
Springer Science and Business Media LLC